Yat Sun Or

2020

In 2020, Yat Sun Or earned a total compensation of $1.8M as Senior Vice President, Research & Development and Chief Scientific Officer at Enanta Pharmaceuticals, a 13% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$184,230
Option Awards$981,504
Salary$472,075
Stock Awards$187,821
Other$19,171
Total$1,844,801

Or received $981.5K in option awards, accounting for 53% of the total pay in 2020.

Or also received $184.2K in non-equity incentive plan, $472.1K in salary, $187.8K in stock awards and $19.2K in other compensation.

Rankings

In 2020, Yat Sun Or's compensation ranked 5,891st out of 13,090 executives tracked by ExecPay. In other words, Or earned more than 55.0% of executives.

ClassificationRankingPercentile
All
5,891
out of 13,090
55th
Division
Manufacturing
2,418
out of 5,617
57th
Major group
Chemicals And Allied Products
965
out of 2,248
57th
Industry group
Drugs
836
out of 1,948
57th
Industry
Pharmaceutical Preparations
624
out of 1,453
57th

Pay ratio

Yat Sun Or's Pay$1,844,801
Median Employee's Pay$232,629
Pay Ratio

8

to 1

In 2020, the annual total compensation of Yat Sun Or was $1,844,801.

The annual total compensation of the median employee at Enanta Pharmaceuticals was $232,629.

The ratio of Yat Sun Or's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on January 21, 2021.

Or's colleagues

We found four more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2020.

2020

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2020

Nathalie Adda

Enanta Pharmaceuticals

Chief Medical Officer

2020

Nathaniel Gardiner

Enanta Pharmaceuticals

General Counsel

2020

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like